| 000 | 00975 a2200253 4500 | ||
|---|---|---|---|
| 005 | 20250514205305.0 | ||
| 264 | 0 | _c20050331 | |
| 008 | 200503s 0 0 eng d | ||
| 022 | _a1521-6926 | ||
| 024 | 7 |
_a10.1016/j.beha.2004.08.006 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRowe, Jacob M | |
| 245 | 0 | 0 |
_aState of the science for myelodysplastic syndrome: prognosis and promise of new therapies. _h[electronic resource] |
| 260 |
_bBest practice & research. Clinical haematology _cDec 2004 |
||
| 300 |
_a535-41 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xclassification |
| 650 | 0 | 4 | _aDrug Delivery Systems |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMyelodysplastic Syndromes _xtherapy |
| 650 | 0 | 4 | _aPrognosis |
| 773 | 0 |
_tBest practice & research. Clinical haematology _gvol. 17 _gno. 4 _gp. 535-41 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.beha.2004.08.006 _zAvailable from publisher's website |
| 999 |
_c15183982 _d15183982 |
||